<DOC>
	<DOCNO>NCT02097407</DOCNO>
	<brief_summary>Dexmedetomidine useful anaesthetic adjuvant general anaesthesia . In prospective randomise study , determine whether preoperative dexmedetomidine administration could reduce half maximal effective concentration ( EC50 ) propofol successful i-gelTM insertion without muscle relaxant .</brief_summary>
	<brief_title>Preoperative Dexmedetomidine &amp; EC50 Propofol</brief_title>
	<detailed_description>Propofol useful induction agent LMA insertion without muscle relaxant profoundly inhibits pharyngeal laryngeal reactivity . A previous report show effect-site concentration propofol successful classic LMA insertion 50 % adult ( EC50 ) without muscle relaxant healthy male patient 8.72 ( 0.55 ) Âµg ml-1 . The EC50 propofol may dependent type LMA use . A previous study compare EC50 propofol concentration classic proseal LMA insertion demonstrate EC50 propofol need proseal LMA insertion 35 % great need classic LMA insertion . Unfortunately , investigation perform determine EC50 propofol concentration require i-gel insertion without muscle relaxant . Dexmedetomidine ( DEX ) , selective alpha-2 agonist , sympatholytic , sedative , analgesic property . Such beneficial characteristic make DEX useful anaesthetic adjuvant general anaesthesia . Many report reveal beneficial effect DEX term reduce intraoperative anaesthetic requirement , postoperative analgesic demand , increased haemodynamic response noxious stimulus endotracheal intubation . A previous investigation show preoperative clonidine , alpha-2 agonist , decrease EC50 require LMA insertion . We hypothesise preoperative DEX administration reduce propofol concentration require i-gel insertion . In study , compare EC50 propofol need successful i-gel insertion without muscle relaxant DEX placebo group</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>ASA physical status III patient 2065 year old schedule general anaesthesia urologic surgery Patients allergy alpha2 adrenergic agonist propofol Patients anticipate difficult airway ( cervical spinal disease , Mallampati score III IV , mouth open &lt; 2.5 cm , and/or body mass index &gt; 30 kg m2 ) , unstable teeth Patients bradycardia &lt; 50 beats/min , heart block great first degree , severe cardiorespiratory dysfunction Patients symptoms upper respiratory infection</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>